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Abstract
Background: This systematic review and meta-analysis aimed to compare recurrence rates of rectal prolapse following ventral mesh
rectopexy (VMR) and suture rectopexy (SR).
Methods: MEDLINE, Embase, and the Cochrane Library were searched for studies reporting on the recurrence rates of complete rectal
prolapse (CRP) or intussusception (IS) after SR and VMR. Results were pooled and procedures compared; a subgroup analysis was per-
formed comparing patients with CRP and IS who underwent VMR using biological versus synthetic meshes. A meta-analysis of stud-
ies comparing SR and VMR was undertaken. The Methodological Items for Non-Randomized Studies score, the Newcastle–Ottawa
Scale, and the Cochrane Collaboration tool were used to assess the quality of studies.
Results: Twenty-two studies with 976 patients were included in the SR group and 31 studies with 1605 patients in the VMR group;
among these studies, five were eligible for meta-analysis. Overall, in patients with CRP, the recurrence rate was 8.6 per cent after SR
and 3.7 per cent after VMR (P< 0.001). However, in patients with IS treated using VMR, the recurrence rate was 9.7 per cent.
Recurrence rates after VMR did not differ with use of biological or synthetic mesh in patients treated for CRP (4.1 versus 3.6 per cent;
P¼ 0.789) and or IS (11.4 versus 11.0 per cent; P¼ 0.902). Results from the meta-analysis showed high heterogeneity, and the difference
in recurrence rates between SR and VMR groups was not statistically significant (P¼ 0.76).
Conclusion: Although the systematic review showed a higher recurrence rate after SR than VMR for treatment of CRP, this result was
not confirmed by meta-analysis. Therefore, robust RCTs comparing SR and biological VMR are required.
Introduction
Complete rectal prolapse (CRP) is defined as full-thickness pro-
trusion of the rectal wall through the anus1. It begins as intussus-
ception (IS) which may or may not be symptomatic2. It is a
common condition worldwide, which can be difficult to treat suc-
cessfully and causes significant psychosocial problems for the
patient. The aim of treatment is to control the prolapse and re-
lieve incontinence while preventing constipation or obstructive
defaecation3,4. Plication of the redundant bowel and/or fixation
of the rectum to the sacrum was originally achieved by SR, but
has evolved to the use of synthetic, non-absorbable mesh.
Recently, mesh rectopexy has been associated with a rise in
chronic pain and morbidity5 and, as a result, a change to more
expensive biological mesh has become the standard6.
SR can be performed laparoscopically or via a laparotomy.
First described by Cutait7 in 1959, SR involves mobilization and
fixation of the rectum with a non-absorbable suture. The act of
mobilization, suture, and fibrosis keeps the rectum fixed in posi-
tion as adhesions form, attaching the rectum to the presacral fas-
cia. Although SR is considered a good option for the cure of rectal
prolapse/IS in both men and women, some reviews of this proce-
dure noted a better overall clinical outcome in men8. This may be
due to occult sphincter defects in women, and failure to detect
these defects before surgery owing to the lack of routine endoa-
nal ultrasonography in the earlier years of prolapse surgery9.
The mesh rectopexy operation was first described by
Ripstein10 in 1952. Again, after mobilization of the rectum, an
anterior sling of synthetic material (either absorbable or non-
absorbable) is placed in front of the rectum and sutured to the sa-
cral promontory. The rationale for this is to restore the natural
curve of the rectum, which reduces the effect of downward ab-
dominal pressure. The use of a non-elastic synthetic graft pro-
vides a firm anterior fascial support even in patients with
significant pelvic floor descent, returning the rectum to a normal
anatomical position11. However, there were long-term complica-
tions associated with the use of synthetic mesh for ventral mesh
rectopexy (VMR)5, so a shift to biological mesh was made.
There is little hard evidence for the use of biological mesh
compared with historical techniques. This systematic review and
meta-analysis aimed to identify the evidence and compare recur-
rence rates for SR with those of VMR for patients with CRP or IS.
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Methods
Data sources and search strategy
Two literature searches were carried out using MEDLINE,
Embase, and the Cochrane Library databases. No limitation on
study period was set and searches were set for studies on SR and
VMR—using either biological or synthetic mesh—using the fol-
lowing criteria: ‘(suture OR sutured) AND rectopex*’ (SR, search 1)
and ‘(ventral OR anterior OR mesh) AND rectopex*’ (VMR, search
2). The reference lists from systematic reviews or meta-analyses
were reviewed and relevant studies included. Titles and abstracts
were screened by two reviewers, and full-text copies were subse-
quently obtained. Any discrepancies in screening were settled by
a third reviewer.
Studies included were randomized and non-randomized stud-
ies using open or laparoscopic techniques that reported either
symptomatic, anatomical or radiological recurrence of CRP (full-
thickness) or IS as outcome measure, as it is the most standard-
ized way of assessing the efficacy of the procedures. Studies were
included only if indication and specific data were available for ex-
traction.
Case reports, duplicates, non-English articles, and those
reporting follow-up of less than 12 months were excluded.
Studies that focused on robotic rectopexy were excluded owing to
the novelty of the technique and absence of a SR robotic group.
Other exclusion criteria were: SR in children, rectocele, volvulus
or mucosal prolapse; and studies that involved posterior recto-
pexy, concomitant resections, sacrocolpopexy or other abdomi-
nal or pelvic procedures directly related to the prolapse or IS.
Studies pertaining to VMR were excluded if they used the
Ripstein procedure/sling rectopexy, Well’s procedure or the Orr–
Loygue procedure, concomitant sacrocolpopexy, or any other
concomitant abdominal or pelvic procedures.
Non-randomized studies were assessed for methodological
quality using the Methodological Index for Non-Randomized
Studies score12, and RCTs were assessed independently for risk of
bias using the Cochrane Collaboration tool13, by two reviewers;
discrepancies were discussed and resolved mutually.
Data extraction and outcome measures
The following information was extracted: study design, title,
authors, publication year, study type, number of patients under-
going rectopexy, population characteristics, type of mesh used
(VMR), duration of follow-up, and number of patients with recur-
rence of CRP or IS (primary outcome). Secondary outcomes in-
cluded incontinence and constipation data, and postoperative
complications reported by the studies. Secondary procedures and
secondary recurrence were excluded, and partial recurrence was
not considered an outcome of interest. In calculation of the com-
plication rate, only studies that reported complications were in-
cluded in the denominator.
Constipation and incontinence data varied among studies, as
various scoring methods (Cleveland and Wexner scores, and
Faecal Incontinence Severity Index) were reported. Data extrac-
tion for these outcomes included type of scoring system used if
available, values from each scoring system, raw figures for
patients with incontinence or constipation before and after oper-
ation if available, and whether the study reported a change in
symptoms to be statistically significant.
Statistical analysis
Data extracted from the studies were pooled for the overall rates
of recurrence and complications. The significance of recurrence
and complication rates was assessed using Pearson’s v2 test in
SPSSVR (IBM, Armonk, New York, USA); P < 0.050 was considered
statistically significant. Constipation and incontinence data were
considered for qualitative analysis. Randomized and non-
randomized studies comparing SR and VMR were eligible for
meta-analysis and statistical comparison of recurrence rates.
The quality of non-randomized studies was assessed using the
Newcastle–Ottawa Scale14 and risk of bias of randomized studies
using the Cochrane Collaboration tool13. Meta-analysis was per-
formed using Review Manager 5.3 (Nordic Cochrane Centre,
Copenhagen Denmark). Risk ratio was the effect measure used
(with 95 per cent confidence interval) and statistical heterogene-
ity was assessed using the I2 test. A random-effects model was to
be used if heterogeneity was high (I2 over 50 per cent) and a fixed-
effect model if heterogeneity was low. Results were represented
visually in a forest plot. P < 0.050 indicated statistical signifi-
cance.
Results
Of 378 citations retrieved from the SR search, 228,9,15–34 were in-
cluded in the review including 976 patients. Of 1419 citations re-
trieved from the VMR search, 31 studies15,21,23,27,30,35–60 were
included in analysis reporting on 1608 patients with CRP and 399
patients with IS (Fig. 1). All studies in the SR group included
patients with CRP. Data for CRP and IS were therefore compared
separately. Studies and their characteristics are summarized in
Tables 1 and 2.
In the VMR group, 27 of the 31 studies reported on patients
with a median or mean age of more than 50 years, and in 25 stud-
ies the study population included more than 80 per cent women.
Similarly, in the SR group, median or mean age exceeded 50 years
in 17 of 21 studies in which age was reported, and in 16 reports
women comprised more than 80 per cent of the included
patients.
Follow-up and recurrences
Follow-up ranged from 12 to 74 months in the VMR group and
from 12 to 162 months in the SR group; it was reported using me-
dian values in 41 studies and as a mean value in seven. Follow-
up data were missing from one VMR study43, although this was
an update of a previous publication that reported a median
follow-up of 61 months61. Among patients treated for CRP, the re-
currence rate was 8.8 per cent in in the SR group and 3.8 per cent
in the VMR group (P < 0.001) (Table 3). However, among 402
patients with IS treated using VMR, the recurrence rate was 9.7
per cent.
Twenty-one studies of VMR reported the use of synthetic
mesh, whereas the use of biological mesh was reported in seven
(Table 4). The remaining VMR studies either did not report the
type of mesh used, or used both types and did not specify which
mesh was used in patients who had recurrence. Synthetic mesh
was used in 1362 patients with CRP across 17 studies, of whom 49
(3.6 per cent) had a recurrence, and in 209 patients with IS across
four studies, of whom 23 (11.0 per cent) developed recurrence.
Biological mesh was used in 97 patients with CRP across five
studies, of whom four (4.1 per cent) had a recurrence, and in 140
patients with IS across two studies, of whom 16 (11.4 per cent) de-
veloped recurrence. There was no significant difference in recur-
rence rates between synthetic or biological mesh for CRP
(P¼ 0.789) or IS (P¼ 0.902),
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Constipation and incontinence
In the VMR group, 27 studies reported data on incontinence and
21 found a statistically significant improvement after surgery
(Table 5). In the SR group, 17 studies reported data on inconti-
nence, eight of which found a statistically significant improve-
ment after operation. One study54 in the VMR group and
five19,25,28,29,31 in the SR group did not report statistical signifi-
cance testing, but suggested an improvement in incontinence. No
studies reported an overall worsening of incontinence.
In the VMR group, 24 studies reported data on constipation
and 14 found a statistically significant improvement after opera-
tion (Table 5). In the SR group, 14 studies reported data on
constipation, two of which found a statistically significant post-
operative improvement. Nine further studies18,25,31,34,42,44,51,52,56
did not report statistical significance testing, but suggested an
improvement in constipation. One study showed a significant
worsening of constipation after SR.
Of five studies that compared SR and VMR, three15,23,27
reported a comparison of incontinence and constipation (Table 6).
Regarding incontinence, two studies found no statistical differ-
ence between VMR and SR, although one27 reported a significant
difference favouring VMR. With respect to constipation, two stud-
ies23,27 reported a statistical difference between VMR and SR,
both favouring VMR; however, one of these studies27 included
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Fig. 1 PRISMA flow diagram showing selection of studies for review
CRP, complete rectal prolapse.
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some patients who had concurrent sigmoid resection with SR.
The third study15 did not perform significance testing on consti-
pation data, but reported a similar worsening after VMR and SR.
Complications
Twelve studies in the SR group reported complications, including
616 patients with 54 complications overall (8.8 per cent) (Table 7).
Twenty-two VMR studies reported complications including 1232
patients and 97 complications overall (7.9 per cent) (P¼ 0.509 for
SR versus VMR). The most common postoperative complications
reported were surgical-site infection after SR (1.9 per cent) and
urinary tract infection after VMR (2.4 per cent).
Meta-analysis
Of the 48 studies, five (2 RCTs and 3 non-randomized studies)
compared recurrence of CRP after SR versus VMR and were there-
fore eligible for meta-analysis (Table 8). Of the randomized stud-
ies, risk of bias assessed using the Cochrane Collaboration tool
was considered to be low in one23 and unclear in the other27 . Of
the three non-randomized studies, one was considered to be of
fair quality (4 of 7)15 and the other two21,30 of high quality (7 of 7
and 6 of 7) (Tables S1 and S2).
Length of follow-up varied between the studies ranging from
12 to 84 months. The method of assessing recurrence of CRP was
robust in all five studies, which reported the use of clinical exam-
ination with or without questionnaires, endoscopy or defaecogra-
phy.
Across the five studies, 269 patients had SR, of whom 26 had a
recurrence (9.7 per cent) and 215 had VMR, of whom 16 developed
recurrence (7.4 per cent). Statistical heterogeneity was high (I2 ¼
73 per cent) and the difference in recurrence rates was not statis-
tically significant (P¼ 0.66; 3 d.f.) (Fig. 2).
Discussion
The concept of fixing the rectum to the sacrum has been a main-
stay in the treatment of rectal prolapse for 35 years. The original
Orr–Loygue procedure, which involves fully mobilizing the rec-
tum circumferentially down to the levator ani muscle, and fixing
an anterior and posterior mesh from the sacrum to the anterolat-
eral rectal wall, has been modified over the years62. The D’Hoore
modified method performed laparoscopically demands only that
Denonvilliers fascia is dissected around the anterior rectal wall
and a single mesh is sutured to the anterior aspect of the distal
rectum. Owing to possible complications of neurological damage,
posterior dissection is avoided in the modified procedure and is
limited only to clear the sacral promontory sufficiently for mesh
fixation to the periosteum43.
Table 1 Characteristics of studies of suture rectopexy















Benoist et al.15 Retrospective 16 76.2† 100 Clinical examination 24† 15 of 24 –
Blatchford et al.16 Retrospective 42 61‡ 88 Office visits/telephone interviews 28 11 of 16 –
Briel et al.9 Retrospective 24 71 88 Hospital records and prospective
telephone interview
67 10 of 16 –
Bruch et al.17 Prospective 32 62† 94 Clinic appointment, continence
score, anorectal manometry
30† 12 of 16 –
Chaudhry Vsm18 Prospective 36 43.5† 72 Not-specified 12 11 of 16 –
De Oliviera et al.19 Retrospective 16 82 88 Examination/patient complaint 29† 16 of 24 –
Foppa et al.20 Prospective 172 62 97.2 Telephone interview and office
appointment
162 13 of 16 –
Gleditsch et al.21 Retrospective 49 72 83 Interview, endoscopy and exami-
nation
84 15 of 24 –
Heah et al.22 Retrospective 25 72‡ 88 Outpatient appointment or tele-
phone review
26 11 of 16 –
Hidaka et al.23 RCT 30 48.5 90 Clinical examination 72 – 3 unclear
4 low risk
Kellokumpu et al.24 Prospective 16 57 91 Appointment at hospital and en-
doscopy
24 14 of 24 –
Kessler et al.8 Retrospective 28 51.5 84 Telephone interview 33 9 of 16 –
Khanna et al.25 Prospective 65 n.a. n.a. n.a. 65 10 of 16 –
Liyanage et al.26 Prospective 70 37 30 Outpatient appointment or tele-
phone/postal review
56 12 of 16 –
Luglio et al.27 RCT 11 68 100 Questionnaire, endoscopy and
defaecography
12 – 5 unclear
2 low risk
McKee et al.28 RCT 8 70† 50 Examination 20 – 5 unclear
2 low risk
Novell et al.29 RCT 32 76 98 Outpatient appointment or tele-
phone/postal review
50 – 3 unclear
3 low risk
1 high risk
Raftopoulos et al.30 Retrospective 163 53 70.9 Patient data 43 16 of 24 –
Sahoo et al.31 Retrospective 32 42.5† n.a. Hospital records 12 15 of 24 –
Senapati et al.32 RCT 35 58† 84 Clinic appointment and ques-
tionnaire
36 – 4 unclear
3 low risk
Wilson et al.33 Prospective 59 72 99 Telephone interview 48 9 of 16 –
Yasukawa et al.34 Case series 15 72.5† 93 Telephone interview 16 10 of 16 –
*Values are median unless indicated otherwise; values are †mean and ‡average. MINORS, Methodological Index for Non-Randomized Studies; n.a., not available.
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When considering synthetic mesh as a material for rectal fixa-
tion, the tensile strength of most synthetic materials usually
exceeds the physiological demand. This excess tensile strength
can lead to an increased local inflammatory response and loss of
elasticity of the mesh. On the other hand, biological meshes are
made from human, bovine or porcine tissue that has been
Table 2 Characteristics of studies of mesh rectopexy
Reference Study type No. of patients Age
(years)*
% women Follow-up method Duration
of follow-up
(months)*







Albayati et al.35 Retrospective 9 42 57 100 Questionnaire and
telephone call
22 Biological 8 of 16 –
Benoist et al.15 Retrospective 14 0 76.2† 100 Clinical examination 24† n.a. 15 of 24 –
Bjerke and
Mynster36
n.a. 40 0 83 100 n.a. 18 Synthetic 7 of 16 –
Boons et al.37 Prospective 65 0 72 92 Clinic appointment
and telephone call
19 Synthetic 11 of 16 –
Brunner et al.38 Prospective 13 0 64.7† 94 Clinical examination
and questionnaire
29 Biological 11 of 16 –
Byrne et al.39 Prospective 126 0 56.2† n.a. Telephone interview
and contacted GP
60 Synthetic 10 of 16 –
Chandra et al.40 Prospective 15 0 50 60 Examination and
long-term tele-
phone consultation
22 Synthetic 10 of 16 –
Collinson et al.41 Prospective 0 75 58 92 Outpatient clinic 12 Synthetic 11 of 16 –
Consten et al.42 Retrospective 242 0 55.8† 94.6 Outpatient clinic 40 Synthetic 11 of 16 –
D’Hoore and
Penninckx43
Prospective 109 0 F: 50
M: 32
91.7 n.a. n.a. Synthetic 9 of 16 –
Emile et al.44 RCT 25 0 39.7† 62 Consultation and ex-
amination
18† Synthetic – 3 unclear
4 low risk
Faucheron et al.45 Prospective 175 0 58† 90.3 Examination 74 Synthetic 12 of 16 –
Franceschilli et al.46 Prospective 0 98 63† 100 Outpatient clinic 20 Biological 13 of 16 –




16 of 24 –




12 Synthetic 10 of 16 –




Prospective 54 0 53† 82 Outpatient clinic 36 Synthetic 12 of 16 –
Lechaux et al.49 Retrospective 35 0 53 92 Clinical review and
postal question-
naire
36 Synthetic 9 of 16 –
Luglio et al.27 RCT 20 0 68 100 Questionnaire, endos-
copy and defaecog-
raphy




Retrospective 41 0 55† 81 Clinical review and
postal question-
naire
46† n.a. 18 of 24 –
Maggiori et al.51 Prospective 20 0 64† 88 Examination or tele-
phone consultation
42 Synthetic 10 of 16 –
Mantoo et al.52 Prospective 23 0 62† n.a. Outpatient clinic 16 Synthetic 19 of 24 –
Mehmood et al.53 Prospective 34 0 59 94 Questionnaire 12 Biological 17 of 24 –
Ogilvie et al.54 Prospective 33 0 72.3† 100 Clinic/examination 16 Synthetic 16 of 24 –
Owais et al.55 Prospective 18 50 34.5 0 Questionnaire 42 Mostly synthetic 9 of 16 –
Portier et al.56 Prospective 0 40 60.6† 100 Outpatient clinic, ex-
amination and
questionnaire
22† Synthetic 9 of 16 –
Raftopoulos et al.30 Retrospective 125 0 53 70.9 Examination in out-
patient clinic or
telephone interview
43 Synthetic 16 of 24 –
Randall et al.57 Prospective 190 0 69 87.4 Appointment 29 Synthetic 11 of 16 –
Tsunoda et al.58 Prospective 0 44 76 100 Questionnaires and
proctography
26 Synthetic 9 of 16 –
Tsunoda et al.59 Retrospective 58 0 80 90 Outpatient clinic, tele-
phone interview,
mail questionnaire
49 Synthetic 10 of 16 –
Wahed et al.60 Prospective 27 0 62 95 examination and
proctogram
12 Biological 11 of 16 –
*Values are median unless indicated otherwise; values are †mean. CRP, complete rectal prolapse; IS, intussusception; MINORS, Methodological Index for Non-
Randomized Studies; n.a., not available.
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decellularized to leave a collagen matrix for native tissue to infil-
trate. The characteristics of each material are unique and depend
on the tissue source, the method used to remove the cells, and
the method of sterilization. However, it is in terms of the safety
profile that biological mesh has become superior to synthetic
mesh63.
Anecdotally, the complication rate associated with biological
mesh appears to be lower than that for synthetic mesh, probably
related to its lower tensile strength, but its cost for VMR remains
a problem. Before the development of VMR, simple sutures were
used for rectopexy. Historically, there have been numerous sub-
tle variations of this technique, but the general consensus was to
use two or three non-absorbable sutures for fixation of the rec-
tum to the sacrum7.
This review aimed to compare recurrence rates following CRP
and IS. However, the SR group did not include any patients with
IS and so a subgroup analysis was performed in the VMR group.
The recurrence rate was higher after SR than VMR in patients
treated for CRP, whereas the subgroup analysis of patients who
underwent VMR showed higher rates in patients with IS than
those with CRP.
Given that biological VMR is the current standard treatment
for CRP and IS, it is important to note that, of the seven studies
(237 patients) that reported the use of biological mesh, the recur-
rence rate was similar to that of SR (recurrence rate of IS and CRP
combined 8.4 per cent after VMR versus 8.8 per cent for CRP after
SR) (Tables 3 and 4) The small number of studies reporting recur-
rence following biological VMR highlights the need for further re-
search. Comparison of the two groups using meta-analysis
showed no statistical difference in recurrence of CRP between
synthetic VMR and SR.
It appears that constipation and incontinence improved more
after VMR. However, poor consistency of reporting, variation in
methods of measuring constipation and incontinence across
studies, and varying interpretation of these methods made com-
parison of studies challenging in this study and reduces the reli-
ability of these results.
Few studies reported postoperative complications and, al-
though complication rates were similar after both procedures,
heterogeneity between studies will have had a considerable im-
pact. Surgical-site infection was by far the most common postop-
erative complication after SR.
The main limitation of this review is the difficulty in compar-
ing a modern technique with a historical technique owing to a
lack of comparative evidence and standardization of methods, in-
equality of reporting, and variation in follow-up. Notably, the
population characteristics in terms of age, sex, and indication for
surgery were similar in the two groups.
Significant variation in duration of follow-up across studies in
both literature searches limited the validity of comparison.
Follow-up varied from 12 to 162 months in the SR studies, and
from 12 to 74 months in the VMR studies, which may have had a
significant effect on the results. Variation in methods of measur-
ing constipation and incontinence across studies, as well as vary-
ing interpretation of these methods, made comparison of studies
challenging.
This review has highlighted that the recurrence rates and
safety of SR and VMR are comparable; however, a robust RCT in
this field is highly advocated.
Disclosure. The authors declare no conflict of interest.
Supplementary material
Supplementary material is available at BJS Open online.






Suture rectopexy 976 86 (8.8)
Benoist et al.15 16 0 (0)
Blatchford et al.16 42 1 (2)
Briel et al.9 24 0 (0)
Bruch et al.17 32 0 (0)
Chaudhry Vsm18 36 1 (3)
De Oliviera et al.19 16 2 (13)
Foppa et al.20 172 30 (17.4)
Gleditsch et al.21 49 15 (31)
Heah et al.22 25 0 (0)
Hidaka et al.23 30 7 (23)
Kellokumpu et al.24 16 2 (13)
Kessler et al.8 28 2 (7)
Khanna et al.25 65 0 (0)
Liyanage et al.26 70 5 (7)
Luglio et al.27 11 3 (27)
McKee et al.28 8 0 (0)
Novell et al.29 32 1 (3)
Raftopoulos et al.30 163 1 (0.1)
Sahoo et al.31 32 0 (0)
Senapati et al.32 35 9 (26)
Wilson et al.33 59 6 (10)





Albayati et al.35 9 1 (11)
Benoist et al.15 14 0 (0)
Bjerke and Mynster36 40 2 (5)
Boons et al.37 65 1 (2)
Brunner et al.38 13 1 (8)
Byrne et al.39 126 5 (4.0)
Chandra et al.40 15 0 (0)
Consten et al.42 242 13 (5.4)
D’Hoore and Penninckx43 109 4 (3.7)
Emile et al.44 25 2 (8)
Faucheron et al.45 175 2 (1.1)
Gleditsch et al.21 22 3 (14)
Gosselink et al.47 41 1 (2)
Hidaka et al.23 34 3 (9)
Hiltunen and Matikainen48 54 1 (2)
Lechaux et al.49 35 1 (3)
Luglio et al.27 20 1 (5)
Madbouly and Youssef50 41 1 (2)
Maggiori et al.51 20 0 (0)
Mantoo et al.52 23 2 (9)
Mehmood et al.53 34 0 (0)
Ogilvie et al.54 33 5 (15)
Owais et al.55 18 0 (0)
Raftopoulos et al.30 125 9 (7.2)
Randall et al.57 190 1 (0.5)
Tsunoda et al.59 58 1 (2)
Wahed et al.60 27 1 (4)
Recurrence of intussusception 399 39 (9.8)
Albayati et al.35 42 2 (5)
Collinson et al.41 75 4 (5)
Franceschilli et al.46 98 14 (14.3)
Gosselink et al.47 50 3 (6)
Owais et al.55 50 0 (0)
Portier et al.56 40 1 (3)
Tsunoda et al.58 44 15 (34)
Values in parentheses are percentages. P < 0.001, suture rectopexy versus
ventral mesh rectopexy for complete rectal prolapse (Pearson’s v2 test).
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Table 4 Comparison between biological and synthetic mesh for mesh rectopexy
Type of mesh No. of studies Recurrence
CRP IS CRP IS Total
Biological 5 2 4 of 97 (4) 16 of 140 (11.4) 20 of 237 (8.4)
Synthetic 17 4 49 of 1362 (3.6) 23 of 209 (11.0) 72 of 1571 (4.6)
P* 0.789 0.902
Values in parentheses are percentages. CRP, complete rectal prolapse; IS, intussusception. *Pearson’s v2 test.
Table 5 Constipation and incontinence reported in included studies
Incontinence Constipation
Method of measurement Statistically significant im-
provement
Method of measurement Statistically significant im-
provement
Suture rectopexy (CRP)
Benoist et al.15 Raw figures n.s. Raw figures n.s.
Blatchford et al.16 Graded 0–4 and raw fig-
ures
Yes Raw figures No, significantly worse
constipation
Briel et al.9 Browning and Parks Unclear n.a. n.a.
Bruch et al.17 Luebeck continence score Yes Raw figures Yes, but includes some
patients who had re-
section rectopexy
Chaudhry Vsm18 Browning and Parks Yes Raw figures n.s. but 9 of 15 patients
improved
De Oliviera et al.19 Wexner score n.s. but 9 of 11 patients
improved
n.a. n.a.
Foppa et al.20 Wexner score Yes Wexner score No
Gleditsch et al.21 n.a. n.a. n.a. n.a.
Heah et al.22 Browning and Parks Yes Raw figures No
Hidaka et al.23 CCIS n.s. CCCS, PAC-QOL, PAC-
SYM
n.s.
Kellokumpu et al.24 Browning and Parks Yes Numerical symptom
score
Yes
Kessler et al.8 n.a. n.a. n.a. n.a.
Khanna et al.25 Raw figures n.s. but 12 of 16 patients
improved
Raw figures n.s. but 5 of 6 patients im-
proved
Liyanage et al.26 Wexner score, and
Browning and Parks
Yes, but includes some
patients who had re-
section rectopexy
Rome II criteria n.s.
Luglio et al.27 Wexner score n.s. Wexner score n.s.
McKee et al.28 Saline solution infusion
test (raw figures)




Novell et al.29 Browning and Parks, raw
figures
n.s. but 7 of 10 regained
continence to solid and
liquid
n.a. n.a.
Raftopoulos et al.30 n.a. n.a. n.a. n.a.
Sahoo et al.31 Wexner score n.s. but 19 of 21 patients
improved
Wexner score n.s. but 11 of 18 patients
improved
Senapati et al.32 Vaizey score Yes n.a. n.a.
Wilson et al.33 n.a. n.a. n.a. n.a.
Yasukawa et al.34 n.a. n.a. Raw figures n.s. but 4 of 10 patients
improved
Ventral mesh rectopexy (CRP and IS)
Albayati et al.35 (CRP) Raw figures No Raw figures No
Albayati et al.35 (IS) Raw figures Yes Raw figures Yes
Benoist et al.15 (CRP) Raw figures n.s. Raw figures n.s.
Bjerke and Mynster36 (CRP) Wexner score Yes Laxatives use (raw fig-
ures)
No
Boons et al.37 (CRP) FISI Yes Wexner score Yes
Brunner et al.38 (CRP) CCIS Yes CCIS Yes
Byrne et al.39 (CRP) St Mark’s incontinence
score
Yes Visual analogue constipa-




Chandra et al.40 (CRP) FISI Yes Wexner score Yes
Collinson et al.41 (IS) FISI Yes Wexner score Yes
(continued)
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Table 5. (continued)
Incontinence Constipation
Method of measurement Statistically significant im-
provement
Method of measurement Statistically significant im-
provement




Rome II criteria n.s. but 50 of 82 improved
D’Hoore and Penninckx43 (CRP) n.a. n.a. n.a. n.a.
Emile et al.44 (CRP) Wexner score Yes Wexner score n.s. but large improve-
ment in Wexner score
Faucheron et al.45 (CRP) n.a. n.a. n.a. n.a.
Franceschilli et al.46 (IS) FISI Yes Wexner score Yes
Gleditsch et al.21 (CRP) n.a. n.a. n.a. n.a.
Gosselink et al.47 (CRP) FISI Yes Wexner score Yes
Gosselink et al.47 (IS) FISI Yes Wexner score Yes
Hidaka et al.23 CCIS n.s. CCCS, PAC-QOL, PAC-
SYM
n.s.
Hiltunen and Matikainen48 (CRP) Raw figures Yes n.a. n.a.
Lechaux et al.49 (CRP) Wexner score No Wexner score n.s.
Luglio et al.27 (CRP) Wexner score n.s. Wexner score n.s.
Madbouly and Youssef50 (CRP) Wexner score Yes Wexner score Yes
Maggiori et al.51 (CRP) Wexner score Yes Rome II criteria n.s. but 13 of 18 improved
Mantoo et al.52 (CRP) Wexner score Unclear ODS score n.s. but improvement in
mean score
Mehmood et al.53 (CRP) FISI Yes Wexner score Yes
Ogilvie et al.54 (CRP) CCIS n.s. but large improve-
ment in mean CCIS
scores
n.a. n.a.
Owais et al.55 (IS and CRP) CCIS Yes ODS score Yes
Portier et al.56 (IS) CCIS Yes Raw figures n.s. but 13 of 20 improved
Raftopoulos et al.30 n.a. n.a. n.a. n.a.
Randall et al.57 (CRP) CCIS Yes n.a. n.a.
Tsunoda et al.58 (IS) FISI Yes CSS Yes
Tsunoda et al.59 (CRP) FISI Yes CSS Yes
Wahed et al.60 (CRP) Wexner score Yes Wexner score Yes
CRP, complete rectal prolapse; n.s., not stated; n.a., not available; CCIS, Cleveland Clinic Incontinence Score; CCIS, Cleveland Clinic Constipation Score; PAC-QOL,
Patient Assessment of Constipation Quality of Life questionnaire; PAC-SYM, Patient Assessment of Constipation Symptom score; IS, intussusception; FISI, Faecal
Incontinence Severity Index; ODS, obstructive defaecation syndrome; CSS, Constipation Scoring System.
Table 6 Constipation and incontinence in comparative studies
Reference Incontinence Constipation
Method of measurement Results Method of measurement Results
Benoist et al.15 Raw figures No significant difference Raw figures n.s., but similar worsen-
ing in constipation fol-
lowing VMR and SR
Hidaka et al.23 CCIS No significant difference ODS score, CCCS, PAC-QOL, PAC-SYM VMR statistically better
than SR in all parame-
ters
Luglio et al.27 Wexner score VMR statistically better
than SR
Wexner score, Rome III criteria VMR statistically better
than SR; however,
some patients who had
resection rectopexy
were included in SR
group
n.s., Not stated; VMR, ventral mesh rectopexy; SR, suture rectopexy; CCIS, Cleveland Clinic incontinence Score; CCCS, Cleveland Clinic Constipation Score; PAC-
QOL, Patient Assessment of Constipation Quality of Life questionnaire; PAC-SYM, Patient Assessment of Constipation Symptom score.
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Table 7 Summary of complications by procedure
Suture rectopexy (n¼ 616) Mesh rectopexy (n¼ 1232)
Atelectasis 0 (0) 1 (0.1)
Atrial fibrillation 1 (0.2) 0 (0)
Bladder injury 0 (0) 1 (0.1)
Bleeding from port site 1 (0.2) 0 (0)
Deep vein thrombosis 4 (0.6) 0 (0)
Enterocutaneous fistula 0 (0) 0 (0)
Faecal impaction 0 (0) 1 (0.1)
Fluid overload 0 (0) 1 (0.1)
Haematoma 1 (0.2) 10 (0.8)
Hypertension 1 (0.2) 0 (0)
Incisional/port-site hernia 3 (0.5) 7 (0.6)
Infective diarrhoea 2 (0.3) 0 (0)
Intestinal obstruction 4 (0.6) 2 (0.2)
Lumbar discitis 0 (0) 1 (0.1)
Myocardial infarction 0 (0) 1 (0.1)
Non-specific bleeding 1 (0.2) 1 (0.1)
Non-specific infection 0 (0) 2 (0.2)
Pain 0 (0) 6 (0.5)
Pelvic abscess 2 (0.3) 0 (0)
Pelvic collection 1 (0.2) 0 (0)
Perforated bowel 2 (0.3) 3 (0.2)
Peritonitis 1 (0.2) 0 (0)
Pneumonia 3 (0.5) 3 (0.2)
Presacral vein injury 2 (0.3) 0 (0)
Prolonged ileus 1 (0.2) 12 (1.0)
Pulmonary oedema 0 (0) 0 (0)
Respiratory failure 0 (0) 0 (0)
Retrograde ejaculation 0 (0) 0 (0)
Sphincterismus 0 (0) 0 (0)
Subcutaneous emphysema 1 (0.2) 3 (0.2)
Surgical-site infection 12 (1.9) 5 (0.4)
Upper gastrointestinal bleed 0 (0) 0 (0)
Ureteric injury 2 (0.3) 1 (0.1)
Urinary incontinence 0 (0) 2 (0.2)
Urinary retention 6 (1.0) 4 (0.3)
Urinary tract infection 3 (0.5) 29 (2.4)
Wound abscess 0 (0) 1 (0.1)
Total 54 (8.8) 97 (7.9)*
Values in parentheses are percentages. *P ¼0.509 versus suture rectopexy (Pearson’s v2 test).
Table 8 Characteristics of studies included in meta-analysis
Reference Study de-
sign
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Heterogeneity: t 2 = 1.63; c2 = 10.97, 3 d.f., P = 0.01; I 2 = 73%
Test for overall effect: Z = 0.45, P = 0.66
Suture rectopexyReference Ventral mesh rectopexy
Recurrence
Weight (%) Risk ratio Risk ratio
Fig. 2 Forest plot of recurrence after suture rectopexy versus ventral mesh rectopexy for complete rectal prolapse
A Mantel–Haenszel random-effects model was used for meta-analysis. Risk ratios are shown with 95 per cent confidence intervals.
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